APO Research

APO RESEARCH · REPORT

Pulmonary Arterial Hypertension Equipment

Selected research

Market Analysis & Forecast

Global Pulmonary Arterial Hypertension Equipment Market Analysis and Forecast 2026-2032

Market perspective

The global Pulmonary Arterial Hypertension Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pulmonary Arterial Hypertension Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pulmonary Arterial Hypertension Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pulmonary Arterial Hypertension Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pulmonary Arterial Hypertension Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pulmonary Arterial Hypertension Equipment include Medtronic, V-Wave Ltd, Swan-Ganz, SoniVie, Smiths Medical, Pulnovo Medical (Wuxi) Co.,Ltd., Philips, Nonin Medical and Masimo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pulmonary Arterial Hypertension Equipment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pulmonary Arterial Hypertension Equipment, also provides the sales of main regions and countries. Of the upcoming market potential for Pulmonary Arterial Hypertension Equipment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pulmonary Arterial Hypertension Equipment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pulmonary Arterial Hypertension Equipment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pulmonary Arterial Hypertension Equipment sales, projected growth trends, production technology, application and end-user industry.

Pulmonary Arterial Hypertension Equipment Segment by Company

Medtronic

V-Wave Ltd

Swan-Ganz

SoniVie

Smiths Medical

Pulnovo Medical (Wuxi) Co.,Ltd.

Philips

Nonin Medical

Masimo

GE Healthcare

Aria CV

Pulmonary Arterial Hypertension Equipment Segment by Type

Diagnostic Equipment

Treatment Equipment

Pulmonary Arterial Hypertension Equipment Segment by Application

Home Care

Hospital

Clinic

Pulmonary Arterial Hypertension Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Arterial Hypertension Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Arterial Hypertension Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Arterial Hypertension Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pulmonary Arterial Hypertension Equipment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pulmonary Arterial Hypertension Equipment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Arterial Hypertension Equipment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pulmonary Arterial Hypertension Equipment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Equipment Major Manufacturers Table 3. Treatment Equipment Major Manufacturers Table 4. Global Pulmonary Arterial Hypertension Equipment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Home Care Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Pulmonary Arterial Hypertension Equipment Industry Trends Table 9. Pulmonary Arterial Hypertension Equipment Industry Drivers Table 10. Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges Table 11. Pulmonary Arterial Hypertension Equipment Industry Restraints Table 12. Global Pulmonary Arterial Hypertension Equipment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2026) Table 16. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2027-2032) Table 17. Global Pulmonary Arterial Hypertension Equipment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2026) & (k units) Table 19. Global Pulmonary Arterial Hypertension Equipment Sales by Region (2027-2032) & (k units) Table 20. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2021-2026) Table 21. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2027-2032) Table 22. Global Pulmonary Arterial Hypertension Equipment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pulmonary Arterial Hypertension Equipment Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pulmonary Arterial Hypertension Equipment Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pulmonary Arterial Hypertension Equipment Manufacturers, Product Type & Application Table 30. Global Pulmonary Arterial Hypertension Equipment Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pulmonary Arterial Hypertension Equipment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pulmonary Arterial Hypertension Equipment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2026) Table 37. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2027-2032) Table 38. Global Pulmonary Arterial Hypertension Equipment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 40. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 41. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2026) Table 42. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2027-2032) Table 43. Global Pulmonary Arterial Hypertension Equipment Price by Type (2021-2026) & (USD/unit) Table 44. Global Pulmonary Arterial Hypertension Equipment Price by Type (2027-2032) & (USD/unit) Table 45. Global Pulmonary Arterial Hypertension Equipment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2026) Table 49. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2027-2032) Table 50. Global Pulmonary Arterial Hypertension Equipment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 52. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 53. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2026) Table 54. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2027-2032) Table 55. Global Pulmonary Arterial Hypertension Equipment Price by Application (2021-2026) & (USD/unit) Table 56. Global Pulmonary Arterial Hypertension Equipment Price by Application (2027-2032) & (USD/unit) Table 57. Medtronic Company Information Table 58. Medtronic Business Overview Table 59. Medtronic Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio Table 61. Medtronic Recent Development Table 62. V-Wave Ltd Company Information Table 63. V-Wave Ltd Business Overview Table 64. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio Table 66. V-Wave Ltd Recent Development Table 67. Swan-Ganz Company Information Table 68. Swan-Ganz Business Overview Table 69. Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio Table 71. Swan-Ganz Recent Development Table 72. SoniVie Company Information Table 73. SoniVie Business Overview Table 74. SoniVie Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio Table 76. SoniVie Recent Development Table 77. Smiths Medical Company Information Table 78. Smiths Medical Business Overview Table 79. Smiths Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio Table 81. Smiths Medical Recent Development Table 82. Pulnovo Medical (Wuxi) Co.,Ltd. Company Information Table 83. Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview Table 84. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio Table 86. Pulnovo Medical (Wuxi) Co.,Ltd. Recent Development Table 87. Philips Company Information Table 88. Philips Business Overview Table 89. Philips Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Philips Pulmonary Arterial Hypertension Equipment Product Portfolio Table 91. Philips Recent Development Table 92. Nonin Medical Company Information Table 93. Nonin Medical Business Overview Table 94. Nonin Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio Table 96. Nonin Medical Recent Development Table 97. Masimo Company Information Table 98. Masimo Business Overview Table 99. Masimo Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio Table 101. Masimo Recent Development Table 102. GE Healthcare Company Information Table 103. GE Healthcare Business Overview Table 104. GE Healthcare Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio Table 106. GE Healthcare Recent Development Table 107. Aria CV Company Information Table 108. Aria CV Business Overview Table 109. Aria CV Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio Table 111. Aria CV Recent Development Table 112. North America Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 115. North America Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 116. North America Pulmonary Arterial Hypertension Equipment Sales Price by Type (2021-2026) & (USD/unit) Table 117. North America Pulmonary Arterial Hypertension Equipment Sales Price by Type (2027-2032) & (USD/unit) Table 118. North America Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 121. North America Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 122. North America Pulmonary Arterial Hypertension Equipment Sales Price by Application (2021-2026) & (USD/unit) Table 123. North America Pulmonary Arterial Hypertension Equipment Sales Price by Application (2027-2032) & (USD/unit) Table 124. North America Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 128. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 129. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 130. North America Pulmonary Arterial Hypertension Equipment Sales Price by Country (2021-2026) & (USD/unit) Table 131. North America Pulmonary Arterial Hypertension Equipment Sales Price by Country (2027-2032) & (USD/unit) Table 132. United States Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 133. Canada Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 134. Mexico Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 135. Europe Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 138. Europe Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 139. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Type (2021-2026) & (USD/unit) Table 140. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Type (2027-2032) & (USD/unit) Table 141. Europe Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 144. Europe Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 145. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Application (2021-2026) & (USD/unit) Table 146. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Application (2027-2032) & (USD/unit) Table 147. Europe Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 151. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 152. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 153. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Country (2021-2026) & (USD/unit) Table 154. Europe Pulmonary Arterial Hypertension Equipment Sales Price by Country (2027-2032) & (USD/unit) Table 155. Germany Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 156. France Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 157. U.K. Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 158. Italy Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 159. Russia Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 160. Spain Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 163. Sweden Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 164. Poland Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 165. China Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 166. China Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 167. China Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 168. China Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 169. China Pulmonary Arterial Hypertension Equipment Sales Price by Type (2021-2026) & (USD/unit) Table 170. China Pulmonary Arterial Hypertension Equipment Sales Price by Type (2027-2032) & (USD/unit) Table 171. China Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 172. China Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 173. China Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 174. China Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 175. China Pulmonary Arterial Hypertension Equipment Sales Price by Application (2021-2026) & (USD/unit) Table 176. China Pulmonary Arterial Hypertension Equipment Sales Price by Application (2027-2032) & (USD/unit) Table 177. Asia Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 180. Asia Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 181. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Type (2021-2026) & (USD/unit) Table 182. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Type (2027-2032) & (USD/unit) Table 183. Asia Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 186. Asia Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 187. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Application (2021-2026) & (USD/unit) Table 188. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Application (2027-2032) & (USD/unit) Table 189. Asia Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. Asia Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 194. Asia Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 195. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Country (2021-2026) & (USD/unit) Table 196. Asia Pulmonary Arterial Hypertension Equipment Sales Price by Country (2027-2032) & (USD/unit) Table 197. Japan Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 198. South Korea Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 199. India Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 200. Australia Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 206. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 207. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Type (2021-2026) & (USD/unit) Table 208. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Type (2027-2032) & (USD/unit) Table 209. SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 212. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 213. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Application (2021-2026) & (USD/unit) Table 214. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Application (2027-2032) & (USD/unit) Table 215. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 220. SAMEA Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 221. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Country (2021-2026) & (USD/unit) Table 222. SAMEA Pulmonary Arterial Hypertension Equipment Sales Price by Country (2027-2032) & (USD/unit) Table 223. Brazil Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 224. Argentina Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 225. Chile Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 226. Colombia Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 227. Peru Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 229. Israel Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 230. UAE Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 231. Turkey Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 232. Iran Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 233. Egypt Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Pulmonary Arterial Hypertension Equipment Distributors List Table 237. Pulmonary Arterial Hypertension Equipment Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Pulmonary Arterial Hypertension Equipment Image Figure 2. Global Pulmonary Arterial Hypertension Equipment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Arterial Hypertension Equipment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Equipment Image Figure 5. Treatment Equipment Image Figure 6. Global Pulmonary Arterial Hypertension Equipment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pulmonary Arterial Hypertension Equipment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Home Care Image Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Pulmonary Arterial Hypertension Equipment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Figure 13. Global Pulmonary Arterial Hypertension Equipment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2032) Figure 16. Global Pulmonary Arterial Hypertension Equipment Sales (2021-2032) & (k units) Figure 17. Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pulmonary Arterial Hypertension Equipment Sales YoY (2021-2032) & (k units) Figure 20. Europe Pulmonary Arterial Hypertension Equipment Sales YoY (2021-2032) & (k units) Figure 21. China Pulmonary Arterial Hypertension Equipment Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Pulmonary Arterial Hypertension Equipment Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales YoY (2021-2032) & (k units) Figure 24. Global Pulmonary Arterial Hypertension Equipment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pulmonary Arterial Hypertension Equipment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032) Figure 30. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032) Figure 33. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032) Figure 36. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032) Figure 39. North America Pulmonary Arterial Hypertension Equipment Revenue Share by Type (2021-2032) Figure 40. North America Pulmonary Arterial Hypertension Equipment Sales Share by Type (2021-2032) Figure 41. North America Pulmonary Arterial Hypertension Equipment Revenue Share by Application (2021-2032) Figure 42. North America Pulmonary Arterial Hypertension Equipment Sales Share by Application (2021-2032) Figure 43. North America Pulmonary Arterial Hypertension Equipment Revenue Share by Country (2021-2032) Figure 44. North America Pulmonary Arterial Hypertension Equipment Sales Share by Country (2021-2032) Figure 45. Europe Pulmonary Arterial Hypertension Equipment Revenue Share by Type (2021-2032) Figure 46. Europe Pulmonary Arterial Hypertension Equipment Sales Share by Type (2021-2032) Figure 47. Europe Pulmonary Arterial Hypertension Equipment Revenue Share by Application (2021-2032) Figure 48. Europe Pulmonary Arterial Hypertension Equipment Sales Share by Application (2021-2032) Figure 49. Europe Pulmonary Arterial Hypertension Equipment Revenue Share by Country (2021-2032) Figure 50. Europe Pulmonary Arterial Hypertension Equipment Sales Share by Country (2021-2032) Figure 51. China Pulmonary Arterial Hypertension Equipment Revenue Share by Type (2021-2032) Figure 52. China Pulmonary Arterial Hypertension Equipment Sales Share by Type (2021-2032) Figure 53. China Pulmonary Arterial Hypertension Equipment Revenue Share by Application (2021-2032) Figure 54. China Pulmonary Arterial Hypertension Equipment Sales Share by Application (2021-2032) Figure 55. Asia Pulmonary Arterial Hypertension Equipment Revenue Share by Type (2021-2032) Figure 56. Asia Pulmonary Arterial Hypertension Equipment Sales Share by Type (2021-2032) Figure 57. Asia Pulmonary Arterial Hypertension Equipment Revenue Share by Application (2021-2032) Figure 58. Asia Pulmonary Arterial Hypertension Equipment Sales Share by Application (2021-2032) Figure 59. Asia Pulmonary Arterial Hypertension Equipment Revenue Share by Country (2021-2032) Figure 60. Asia Pulmonary Arterial Hypertension Equipment Sales Share by Country (2021-2032) Figure 61. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Share by Type (2021-2032) Figure 62. SAMEA Pulmonary Arterial Hypertension Equipment Sales Share by Type (2021-2032) Figure 63. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Share by Application (2021-2032) Figure 64. SAMEA Pulmonary Arterial Hypertension Equipment Sales Share by Application (2021-2032) Figure 65. SAMEA Pulmonary Arterial Hypertension Equipment Revenue Share by Country (2021-2032) Figure 66. SAMEA Pulmonary Arterial Hypertension Equipment Sales Share by Country (2021-2032) Figure 67. Pulmonary Arterial Hypertension Equipment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pulmonary Arterial Hypertension Equipment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Equipment
  • Treatment Equipment
Applications
  • Home Care
  • Hospital
  • Clinic
Companies covered
  • Medtronic
  • V-Wave Ltd
  • Swan-Ganz
  • SoniVie
  • Smiths Medical
  • Pulnovo Medical (Wuxi) Co.,Ltd.
  • Philips
  • Nonin Medical
  • Masimo
  • GE Healthcare
  • Aria CV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pulmonary Arterial Hypertension Equipment Market by Type
  3. 1.2.1 Global Pulmonary Arterial Hypertension Equipment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic Equipment
  5. 1.2.3 Treatment Equipment
  6. 1.3 Pulmonary Arterial Hypertension Equipment Market by Application
  7. 1.3.1 Global Pulmonary Arterial Hypertension Equipment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Home Care
  9. 1.3.3 Hospital
  10. 1.3.4 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pulmonary Arterial Hypertension Equipment Market Dynamics
  1. 2.1 Pulmonary Arterial Hypertension Equipment Industry Trends
  2. 2.2 Pulmonary Arterial Hypertension Equipment Industry Drivers
  3. 2.3 Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges
  4. 2.4 Pulmonary Arterial Hypertension Equipment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pulmonary Arterial Hypertension Equipment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Region
  3. 3.2.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2021-2026)
  5. 3.2.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2027-2032)
  6. 3.2.4 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pulmonary Arterial Hypertension Equipment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pulmonary Arterial Hypertension Equipment Sales by Region
  9. 3.4.1 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2026)
  11. 3.4.3 Global Pulmonary Arterial Hypertension Equipment Sales by Region (2027-2032)
  12. 3.4.4 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Manufacturers
  2. 4.1.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pulmonary Arterial Hypertension Equipment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pulmonary Arterial Hypertension Equipment Sales by Manufacturers
  6. 4.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pulmonary Arterial Hypertension Equipment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pulmonary Arterial Hypertension Equipment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pulmonary Arterial Hypertension Equipment Manufacturers, Product Type & Application
  13. 4.7 Global Pulmonary Arterial Hypertension Equipment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pulmonary Arterial Hypertension Equipment Market CR5 and HHI
  16. 4.8.2 2025 Pulmonary Arterial Hypertension Equipment Tier 1, Tier 2, and Tier 3
5 Pulmonary Arterial Hypertension Equipment Market by Type
  1. 5.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Type
  2. 5.1.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pulmonary Arterial Hypertension Equipment Sales by Type
  6. 5.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pulmonary Arterial Hypertension Equipment Price by Type
6 Pulmonary Arterial Hypertension Equipment Market by Application
  1. 6.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Application
  2. 6.1.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pulmonary Arterial Hypertension Equipment Sales by Application
  6. 6.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pulmonary Arterial Hypertension Equipment Price by Application
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 V-Wave Ltd
  8. 7.2.1 V-Wave Ltd Company Information
  9. 7.2.2 V-Wave Ltd Business Overview
  10. 7.2.3 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio
  12. 7.2.5 V-Wave Ltd Recent Developments
  13. 7.3 Swan-Ganz
  14. 7.3.1 Swan-Ganz Company Information
  15. 7.3.2 Swan-Ganz Business Overview
  16. 7.3.3 Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio
  18. 7.3.5 Swan-Ganz Recent Developments
  19. 7.4 SoniVie
  20. 7.4.1 SoniVie Company Information
  21. 7.4.2 SoniVie Business Overview
  22. 7.4.3 SoniVie Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio
  24. 7.4.5 SoniVie Recent Developments
  25. 7.5 Smiths Medical
  26. 7.5.1 Smiths Medical Company Information
  27. 7.5.2 Smiths Medical Business Overview
  28. 7.5.3 Smiths Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
  30. 7.5.5 Smiths Medical Recent Developments
  31. 7.6 Pulnovo Medical (Wuxi) Co.,Ltd.
  32. 7.6.1 Pulnovo Medical (Wuxi) Co.,Ltd. Company Information
  33. 7.6.2 Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview
  34. 7.6.3 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio
  36. 7.6.5 Pulnovo Medical (Wuxi) Co.,Ltd. Recent Developments
  37. 7.7 Philips
  38. 7.7.1 Philips Company Information
  39. 7.7.2 Philips Business Overview
  40. 7.7.3 Philips Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Philips Pulmonary Arterial Hypertension Equipment Product Portfolio
  42. 7.7.5 Philips Recent Developments
  43. 7.8 Nonin Medical
  44. 7.8.1 Nonin Medical Company Information
  45. 7.8.2 Nonin Medical Business Overview
  46. 7.8.3 Nonin Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
  48. 7.8.5 Nonin Medical Recent Developments
  49. 7.9 Masimo
  50. 7.9.1 Masimo Company Information
  51. 7.9.2 Masimo Business Overview
  52. 7.9.3 Masimo Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio
  54. 7.9.5 Masimo Recent Developments
  55. 7.10 GE Healthcare
  56. 7.10.1 GE Healthcare Company Information
  57. 7.10.2 GE Healthcare Business Overview
  58. 7.10.3 GE Healthcare Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio
  60. 7.10.5 GE Healthcare Recent Developments
  61. 7.11 Aria CV
  62. 7.11.1 Aria CV Company Information
  63. 7.11.2 Aria CV Business Overview
  64. 7.11.3 Aria CV Pulmonary Arterial Hypertension Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio
  66. 7.11.5 Aria CV Recent Developments
8 North America
  1. 8.1 North America Pulmonary Arterial Hypertension Equipment Market Size by Type
  2. 8.1.1 North America Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  3. 8.1.2 North America Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  4. 8.1.3 North America Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
  5. 8.2 North America Pulmonary Arterial Hypertension Equipment Market Size by Application
  6. 8.2.1 North America Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  7. 8.2.2 North America Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 8.2.3 North America Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
  9. 8.3 North America Pulmonary Arterial Hypertension Equipment Market Size by Country
  10. 8.3.1 North America Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pulmonary Arterial Hypertension Equipment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pulmonary Arterial Hypertension Equipment Market Size by Type
  2. 9.1.1 Europe Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  4. 9.1.3 Europe Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
  5. 9.2 Europe Pulmonary Arterial Hypertension Equipment Market Size by Application
  6. 9.2.1 Europe Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 9.2.3 Europe Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
  9. 9.3 Europe Pulmonary Arterial Hypertension Equipment Market Size by Country
  10. 9.3.1 Europe Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pulmonary Arterial Hypertension Equipment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pulmonary Arterial Hypertension Equipment Market Size by Type
  2. 10.1.1 China Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  3. 10.1.2 China Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  4. 10.1.3 China Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
  5. 10.2 China Pulmonary Arterial Hypertension Equipment Market Size by Application
  6. 10.2.1 China Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  7. 10.2.2 China Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 10.2.3 China Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pulmonary Arterial Hypertension Equipment Market Size by Type
  2. 11.1.1 Asia Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  4. 11.1.3 Asia Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
  5. 11.2 Asia Pulmonary Arterial Hypertension Equipment Market Size by Application
  6. 11.2.1 Asia Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 11.2.3 Asia Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
  9. 11.3 Asia Pulmonary Arterial Hypertension Equipment Market Size by Country
  10. 11.3.1 Asia Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pulmonary Arterial Hypertension Equipment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pulmonary Arterial Hypertension Equipment Market Size by Type
  2. 12.1.1 SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
  5. 12.2 SAMEA Pulmonary Arterial Hypertension Equipment Market Size by Application
  6. 12.2.1 SAMEA Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
  9. 12.3 SAMEA Pulmonary Arterial Hypertension Equipment Market Size by Country
  10. 12.3.1 SAMEA Pulmonary Arterial Hypertension Equipment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pulmonary Arterial Hypertension Equipment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pulmonary Arterial Hypertension Equipment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pulmonary Arterial Hypertension Equipment Value Chain Analysis
  2. 13.1.1 Pulmonary Arterial Hypertension Equipment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pulmonary Arterial Hypertension Equipment Production Mode & Process
  6. 13.2 Pulmonary Arterial Hypertension Equipment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pulmonary Arterial Hypertension Equipment Distributors
  9. 13.2.3 Pulmonary Arterial Hypertension Equipment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research